• 1
    Roberts JM, Redman CWG. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet 1993; 341:14471451.
  • 2
    Redman CWG. Hypertension in pregnancy. In Chamberlain, G, editor. Turnbull's Ohstetrics. London : Churchill Livingstone, 1995: 441470.
  • 3
    Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A and inhibin A as possible endocrine markers of pre-eclampsia. Lancet 1997; 349: 12851288.
  • 4
    Cuckle HS, Holding S, Jones R, Groom NP, Wallace EM. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 1996; 16: 10951100.
  • 5
    Levene RJ, Hauth JC, Curet LB et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997; 337: 6976.
  • 6
    CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention of preeclampsia among 9364 pregnant women. Lancet 1994; 343: 619629.
  • 7
    Wald NJ, Watt HC. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diagn 1996; 16699703.
  • 8
    Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol 1997; 177: 10031010.
  • 9
    Muller F, Savey L, Le Fiblec B et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for ere-eclampsia. Am J Obstet Gynecol 1996; 175: 3740.
  • 10
    Friedman-SA, Schiff E, Emeis JJ, Dekker GA, Sibai BM. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Ohstet Gynecul 1995; 172:202203.
  • 11
    Padriberg KM, DeJong CLD, Van Geijn HP, Van Kamp GJ. Heinen AGJJ, Dekker GA. Total plasma fibronectin as a marker of pregnancy-induced hypertensive disorders: a longitudinal study. Obstet Gynecul 1998; 91: 383388.
  • 12
    Petraglia F, Aguzolli L, Gallinelli A et al. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 1995: 16: 447454.